The CSF levels of total-tau and phosphotau in patients with relapsing-remitting multiple sclerosis (Q48823169)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 July 2005

edit

Language	Label	Description	Also known as
English	The CSF levels of total-tau and phosphotau in patients with relapsing-remitting multiple sclerosis	scientific article published on 6 July 2005

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15997419

retrieved

15 February 2018

reference URL

http://europepmc.org/abstract/MED/15997419

title

The CSF levels of total-tau and phosphotau in patients with relapsing-remitting multiple sclerosis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15997419

retrieved

15 February 2018

reference URL

http://europepmc.org/abstract/MED/15997419

main subject

relapsing-remitting multiple sclerosis

0 references

multiple sclerosis

0 references

author

Halina Bartosik-Psujek

series ordinal

1

object named as

H Bartosik-Psujek

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15997419

retrieved

15 February 2018

reference URL

http://europepmc.org/abstract/MED/15997419

author name string

Z Stelmasiak

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15997419

retrieved

15 February 2018

reference URL

http://europepmc.org/abstract/MED/15997419

publication date

6 July 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15997419

retrieved

15 February 2018

reference URL

http://europepmc.org/abstract/MED/15997419

published in

Journal of Neural Transmission

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15997419

retrieved

15 February 2018

reference URL

http://europepmc.org/abstract/MED/15997419

volume

113

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15997419

retrieved

15 February 2018

reference URL

http://europepmc.org/abstract/MED/15997419

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15997419

retrieved

15 February 2018

reference URL

http://europepmc.org/abstract/MED/15997419

page(s)

339-345

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15997419

retrieved

15 February 2018

reference URL

http://europepmc.org/abstract/MED/15997419

cites work

Tau alteration and neuronal degeneration in tauopathies: mechanisms and models

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00702-005-0327-Z

retrieved

21 January 2018

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00702-005-0327-Z

retrieved

21 January 2018

CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebrospinal fluid tau levels increase with age in healthy individuals

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tau protein and the neurofibrillary pathology of Alzheimer's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased cerebrospinal fluid tau protein in multiple sclerosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated total tau/phospho-tau ratio in autopsy-proven Creutzfeldt-Jakob disease with negative 14-3-3 test results

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functions and malfunctions of the tau proteins

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The 14-3-3 protein in multiple sclerosis: a marker of disease severity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Critique of experimental trials of therapy in multiple sclerosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15997419

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00702-005-0327-Z

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15997419

retrieved

15 February 2018

reference URL

http://europepmc.org/abstract/MED/15997419

PubMed publication ID

15997419

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15997419

retrieved

15 February 2018

reference URL

http://europepmc.org/abstract/MED/15997419

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48823169&oldid=2211015708"